ATE487947T1 - Verfahren zur diagnose und behandlung auf nr2- peptiden beruhender zerebrovaskulärer ereignisse - Google Patents

Verfahren zur diagnose und behandlung auf nr2- peptiden beruhender zerebrovaskulärer ereignisse

Info

Publication number
ATE487947T1
ATE487947T1 AT06773062T AT06773062T ATE487947T1 AT E487947 T1 ATE487947 T1 AT E487947T1 AT 06773062 T AT06773062 T AT 06773062T AT 06773062 T AT06773062 T AT 06773062T AT E487947 T1 ATE487947 T1 AT E487947T1
Authority
AT
Austria
Prior art keywords
diagnosing
peptides
cerebrovascular events
treating cerebrovascular
events related
Prior art date
Application number
AT06773062T
Other languages
English (en)
Inventor
Svetlana Dambinova
Original Assignee
Cis Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cis Biotech Inc filed Critical Cis Biotech Inc
Application granted granted Critical
Publication of ATE487947T1 publication Critical patent/ATE487947T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT06773062T 2005-06-13 2006-06-13 Verfahren zur diagnose und behandlung auf nr2- peptiden beruhender zerebrovaskulärer ereignisse ATE487947T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68980605P 2005-06-13 2005-06-13
PCT/US2006/023020 WO2006135893A2 (en) 2005-06-13 2006-06-13 Methods for diagnosing and treating cerebrovascular events based on nr2 peptides

Publications (1)

Publication Number Publication Date
ATE487947T1 true ATE487947T1 (de) 2010-11-15

Family

ID=37532899

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06773062T ATE487947T1 (de) 2005-06-13 2006-06-13 Verfahren zur diagnose und behandlung auf nr2- peptiden beruhender zerebrovaskulärer ereignisse

Country Status (9)

Country Link
US (2) US8084225B2 (de)
EP (1) EP1899726B1 (de)
JP (1) JP2008547002A (de)
CN (1) CN101268370A (de)
AT (1) ATE487947T1 (de)
CA (1) CA2610833A1 (de)
DE (1) DE602006018145D1 (de)
RU (1) RU2008101419A (de)
WO (1) WO2006135893A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6896872B2 (en) 2001-06-27 2005-05-24 Svetlana A. Dambinova Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
US20060257943A1 (en) * 2005-01-25 2006-11-16 Cis Biotech, Inc. Ischemic biomarkers and their use to predict adverse neurological events from surgery
US20080081980A1 (en) * 2006-09-18 2008-04-03 Michael Maschke Apparatus and process for stroke examination and treatment using a C-arch X-ray system
WO2010096331A1 (en) 2009-02-11 2010-08-26 Duke University Sensors incorporating antibodies and methods of making and using the same
US20140274975A1 (en) 2013-03-13 2014-09-18 Health Diagnostic Laboratory, Inc. Method of determining prior history of ischemic stroke for current risk evaluation and therapy guidance
US10407716B2 (en) 2014-03-13 2019-09-10 Duke University Electronic platform for sensing and control of electrochemical reactions
RU2668534C1 (ru) * 2017-07-18 2018-10-01 Общество с ограниченной ответственностью "ДРД" Диагностический набор реагентов для выявления хронических патологий мозга ишемического генеза
US20220262496A1 (en) * 2018-09-21 2022-08-18 The Regents Of The University Of California Generation of personalized neuroprotective and cardioprotective nutrition programs featuring caloric restriction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU696922B2 (en) * 1993-04-20 1998-09-24 Merck & Co., Inc. Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
WO2002012892A2 (en) 2000-08-04 2002-02-14 Cis Biotech, Inc. Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke
US6896872B2 (en) * 2001-06-27 2005-05-24 Svetlana A. Dambinova Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
AU2004288717A1 (en) * 2003-11-06 2005-05-26 Grace Laboratories, Inc. Immunosorbent blood tests for assessing paroxysmal cerebral discharges

Also Published As

Publication number Publication date
DE602006018145D1 (de) 2010-12-23
US20060281135A1 (en) 2006-12-14
RU2008101419A (ru) 2009-07-20
WO2006135893A3 (en) 2007-03-01
EP1899726A4 (de) 2009-02-25
JP2008547002A (ja) 2008-12-25
WO2006135893A2 (en) 2006-12-21
CA2610833A1 (en) 2006-12-21
CN101268370A (zh) 2008-09-17
EP1899726B1 (de) 2010-11-10
EP1899726A2 (de) 2008-03-19
US20090181006A1 (en) 2009-07-16
US8084225B2 (en) 2011-12-27

Similar Documents

Publication Publication Date Title
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
DE602005024639D1 (de) Verfahren und Gerät zur Diagnose des Ermüdungsversagens von Turboladern
EP2041317A4 (de) Mikro-rna-basierte verfahren und zusammensetzungen zur diagnose und behandlung von erkrankungen in zusammenhang mit darmkrebs
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
UA101167C2 (ru) Фармацевтическая композиция, предназначенная для лечения глазной болезни
EP2215257A4 (de) Verfahren zur diagnose von tumorerkrankungen
WO2008091814A3 (en) Assessment of asthma and allergen-dependent gene expression
EP2091551A4 (de) Verfahren zur diagnose und behandlung von asthma
WO2007146229A3 (en) Markers associated with arteriovascular events and methods of use thereof
BR112012009846B8 (pt) método in vitro e kit para detecção de um anticorpo antifármaco de isotipo ige, e uso de um anticorpo antifármaco de isotipo ige no tratamento de distúrbio mediado por ige
MX2009013649A (es) Variantes geneticas en el cromosoma 15q24 como marcadores para usarse en diagnostico, prognosis y tratamiento de sindrome de exfoliacion y glaucoma.
EP1991274A4 (de) Verfahren zur behandlung, prophylaxe und diagnose von knochenerkrankungen
WO2006073682A3 (en) Diagnostic test
ATE487947T1 (de) Verfahren zur diagnose und behandlung auf nr2- peptiden beruhender zerebrovaskulärer ereignisse
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
EP2291544A4 (de) Genetische veränderungen auf chromosomen 21q, 6q und 15q sowie verfahren zur verwendung davon bei der diagnose und behandlung von typ-i-diabetes
EA201100253A1 (ru) Глутаминилциклаза в качестве диагностического/прогностического индикатора нейродегенеративных заболеваний
MX2021009281A (es) Metodos de deteccion de legionella.
WO2012074550A3 (en) Methods to assess treatment outcomes in reward deficiency syndrome (rds) behaviors utilizing expression profiling
DE602006014106D1 (de) Verfahren zur diagnose von prostatakrebs
DE502006008028D1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen
ATE542570T1 (de) Verwendung kardiotonischer steroiden als na/k- atpase liganden zur hautbehandlung
DE602006009786D1 (de) Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten
ATE525481T1 (de) Verfahren zur diagnose thromboembolischer erkrankungen und koronarer herzerkrankungen
DE602008004556D1 (de) Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties